Pradžia › Berkito limfoma › Ohio › Columbus

Berkito limfoma klinikiniai tyrimai Columbus, OH

8 tyrimai dėl Berkito limfoma ieško dalyvių vietose Columbus ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Renkami dalyviai2 fazė

Nationwide Children's Hospital, Columbus

366 Days – 46 Years · Visoms lytims · Atnaujinta 2026-10-02 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Renkami dalyviai3 fazė

Ohio State University Comprehensive Cancer Center, Columbus

Amžius nuo 18 iki 39 · Visoms lytims · Atnaujinta 2026-10-02 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Renkami dalyviai2 fazė

Ohio State University Comprehensive Cancer Center, Columbus

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Renkami dalyviai2 fazė

Nationwide Children's Hospital, Columbus

Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-09-01 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Renkami dalyviai3 fazė

Nationwide Children's Hospital, Columbus

365 Days – 25 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03959085

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Renkami dalyviai1/2 fazė

The Ohio State University Wexner Medical Center, Columbus

Amžius nuo 13 iki 90 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06533579

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Renkami dalyviai1 fazė

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-05-29 · NCT05418088

Study of SGR-1505 in Mature B-Cell Neoplasms

Renkami dalyviai1 fazė

The Ohio State University - The James Cancer Hospital, Columbus

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-13 · NCT05544019

Berkito limfoma tyrimai kituose miestuose

Kiti tyrimai Columbus

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.